Mouth-Dispersible Aspirin in the Treatment of Migraine: A Placebo-Controlled Study

Objective.—To compare the efficacy of mouth‐dispersible aspirin 900 mg and placebo in the treatment of migraine. Background.—Aspirin is widely accepted as an effective therapy for migraine. Previous studies have indicated that gastric stasis and delayed gastric emptying, which occur during migraine...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Headache 2002-04, Vol.42 (4), p.249-255
Hauptverfasser:	MacGregor, E. Anne, Dowson, Andrew, Davies, Paul T.G.
Format:	Artikel
Sprache:	eng
Schlagworte:	Abdominal Pain - chemically induced Administration, Oral Adult Aged Anti-Inflammatory Agents, Non-Steroidal - administration & dosage Anti-Inflammatory Agents, Non-Steroidal - adverse effects aspirin Aspirin - administration & dosage Aspirin - adverse effects Biological and medical sciences Cardiovascular system Cross-Over Studies Double-Blind Method Female Humans Male Medical sciences Middle Aged migraine Migraine Disorders - drug therapy mouth dispersible Nausea - chemically induced Neurology Pharmacology. Drug treatments Time Factors Treatment Outcome Vascular diseases and vascular malformations of the nervous system Vasodilator agents. Cerebral vasodilators Vomiting - chemically induced
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!